Journal

JAMA Network Open

Publication Date

7-22-2022

Volume

5

Issue

7

First Page

e2223253

Document Type

Open Access Publication

DOI

10.1001/jamanetworkopen.2022.23253

zoi220659supp1_prod_1660657745.2541.pdf (475 kB)
eAppendix. Severe Outcomes eTable 1. Demographic and Clinical Characteristics of SARS-CoV-2-Positive Children by Follow-up Status at 90 Days eTable 2. Baseline Demographics of Participants and Presence of Self-Reported Persistent, New or Recurring Health Problems 90 Days Following ED Visit for 1884 SARS-CoV-2-Positive Children Enrolled Before January 20, 2021 eTable 3. Characteristics of Self-Reported Persistent, New or Recurring Health Problems 90 Days Following the Index ED Visit for SARS-CoV-2-Positive Participants eTable 4. Demographic and Clinical Characteristics (at Time of ED Presentation) of Frequency Matched SARS-CoV-2-Positive and SARS-CoV-2-Negative Children With Complete Follow-up, by Acute Hospitalization Status eTable 5. Comparison of Each Reported Type of Persistent, New or Recurring Health Problem Reported Among Frequency Matched SARS-CoV-2-Positive and Negative Participants With Complete 90-Day Follow-up eTable 6. Results of Multiple Logistic Regression Models Examining the Association of SARS-CoV-2 Positivity With Categories of Reported 90-Day Persistent, New or Recurring Health Problems eFigure 1. Types of 90-Day Persistent, New or Recurring Health Problem According to Number of Health Problems Reported Among the 110 SARS-CoV-2-Positive Children Reporting Any Persistent New or Recurring Health Problem eFigure 2. Follow-up of Frequency Matched SARS-CoV-2-Positive and Negative Children Who Were Not Hospitalized During the Acute Phase (Day 0-14) of Illness eFigure 3. Follow-up of Frequency Matched SARS-CoV-2-Positive and Negative Children Who Were Hospitalized During the Acute Phase (Day 0-14) of Illness

zoi220659supp2_prod_1660657745.26908.pdf (132 kB)
Nonauthor Collaborators

2022_cx_220121_1659727493.1581.pdf (163 kB)
Correction: Error in Byline

Share

COinS